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ciency of surveillance as awhole, including the implementation of
new joint tools or the pooling of existing teams, tools or skills,
especially in relation with information distribution, data man-
agement and outbreaks investigation. Assessing surveillance sys-
tems for animal diseases is necessary to ensure they meet their
objectives and provide high-quality health information. OASIS is a
standardized tool which facilitates comparison and readily high-
lights the individual strengths of each component as opportunities
that could be extended to other components. This research has
used the “OASIS Flash” method, which reduces the time required
for the collection of information about the surveillance systems’
operations and structure, compared with classical OASIS method.
Our study is an original application of OASIS because several sys-
temswere evaluated simultaneouslyand compared. This approach
requires minimal ﬁnancial resources and is not very time-
consuming. Such a comparative evaluation could conceivably be
applied to other surveillance systems, other industries and other
countries. This approach would be especially relevant to enhance
the efﬁciency of surveillance activities when resources are limited.
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The Complement Fixation test (CFT) is the prescribed sero-diag-
nostic method for glanders for international trade. However, its
sensitivity and speciﬁcity has been questioned. False-negative
glanders test results may lead to the introduction of the infectious
agent into a glanders free-region and false-positive test results
may lead to unnecessary restrictions on international trade ofanimals and result in ﬁnancial losses for owners and the equine
industry. CFT alternative methods such as Western blot (WB) and
ELISAs have been developed but have not been fully validated to
date according to the principles and methods of validation of
diagnostic assays for infectious diseases. This project is funded by
OIE and aims the further development and ﬁnalization of vali-
dation of alternative methods like indirect ELISA including re-
combinant ELISA already developed in several laboratories
worldwide. The WB technique developed by the OIE-reference
laboratory, Germany, has given promising results during the last
years using the CFT and theWB in a two-cascade testing approach
[1, 2]. The iELISAs developed by the project partners EU Reference
Laboratory for Equine diseases, France and the Universidade
Federal Rural de Pernambuco, Departamento de Medicina Vet-
erinaria, Brazil using semi-puriﬁed B. mallei antigenic fractions as
well as the recombinant ELISA developed by the National
Research Centre on Equines, Hisar, India gave encouraging results
[3, 4].
The project is sub-divided into work packages (WP). WP1-
‘Constitution of a qualiﬁed sample collection’ of “true positive”
and “true negative”. Special attention will be given to the inclu-
sion of ﬁeld samples from endemic countries like Brazil, India and
Pakistan. WP2- ‘Producing standard sera for glanders’. Serum
from glandered animals identiﬁed in WP1 will be collected to
produce a large stock of positive sera as possibly international
standard for glanders serodiagnosis. These sera will be available
for thewhole community as standard control reagents and will be
included in the panel of sera for the validation pathway (WP3).
WP3- ‘Serological tests validation following OIE validation
pathway’. Performance of tests to be evaluated will be investi-
gated in parallel using sera collected in WP1. The validation will
include the analytical performance characteristics; repeatability,
analytical speciﬁcity including exclusivity and exclusivity. All tests
will be validated and compared regarding sensitivity using the
same panel of true positive samples. The test speciﬁcity is the
most discussed issue in glanders serological diagnosis. However,
the sample collection for the validation will include negative
samples from different regions. For example our partners from
Pakistan (University of Agriculture, Fasialabad) and Brazil
(Reference laboratory for Glanders, Recife) will contribute by
providing large sample collections.
Finally, for all tests the positive and negative predictive values
should be calculable based on actual prevalence situation in the
involved region, and allow to select the right test for the
respective situation, as there are eradication scenarios, surveil-
lance after being free of glanders, or for trade of animals. To
contribute to the availability of the tests upon validation, com-
panies will be encouraged to commercialize the ELISA and also
transform the technology into a faster ﬂow through assay (WP4).
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Equine viral arteritis (EVA) is a cause of abortion and neonatal
deaths. In France, surveillance of EVA is based mostly on sero-
logical testing of all or part of the breeding horses, depending on
the studbooks’ regulations. Hence, EVA incidence is not precisely
known in the overall breeding population. The ﬁrst objective of
this study was to estimate the number of EVA cases and out-
breaks detected by the equine breeding stock surveillance be-
tween 2006 and 2013 in France, by establishing suitable rules for
identiﬁcation of seroconversion. The second objective was to
assess the surveillance sensitivity, after having estimated the
total number of outbreaks that occurred in breeding stock during
this period using a capture-recapture model. Data from breeding
mares which exhibited at least one positive result in serology
using viral neutralization test between 2006 and 2013 were used
for analysis (n¼1,645). Data consisted of the annual antibody
titers and the location of the mares (towns). Seroconversion was
deﬁned as a change in antibody titer from negative to at least 32
or a three-fold increase. The number of seroconversions was
counted for each town and modeled using an unilist zero-trun-
cated binomial (ZTB) capture-recapture model with R software.
The binomial denominator was the number of horses tested in
each infected town. From 2006 to 2013, 239 cases of serocon-
version located in 177 towns (outbreaks) were identiﬁed. During
this period, the number of outbreaks in breeding stock was
estimated at 1,482 (CI95% 1,257-1,815) using the ZTB model.
Consequently, it is estimated that over 1,000 outbreaks were not
detected and the surveillance sensitivity at the town level was
estimated around 12% (CI95% 10%-14%). This study revealed a
signiﬁcant number of outbreaks in breeding stock. However, the
surveillance sensitivity seems underestimated, especially due to
lack of details related to the holdings, such as the number of at
risk contacts or their precise address (the holdings list was not
available and several holdings may be located within the same
town). Nevertheless, the sensitivity could certainly be improved
by including more breeding horses in the active surveillance.
This study is the ﬁrst in France to estimate the EVA incidence in
breeding stock and to assess quantitatively the surveillance
sensitivity. Moreover, the rules for identiﬁcation of seroconver-
sion deﬁned in this study may be used to analyze other EVA
surveillance datasets based on serology, such as testing before
sales or international trade, and even compulsory or voluntarypassive surveillance. Such rules, adjusted to the local environ-
ment, could conceivably be applied in other countries with EVA
surveillance programs.085
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Equinella (www.equinella.ch) is a Swiss voluntary veterinary
reporting system for equine infectious diseases ﬁrst established in
1990. It focuses on equine diseases not notiﬁable by Swiss law. In
2012, an evaluation of the old paper-based system showed that it
was not representative anymore(1). Based on the ﬁndings from a
survey, a new electronic reporting system was developed as a
collaboration between the Federal Food Safety and Veterinary
Ofﬁce, stakeholders from research (Vetsuisse Faculty, Bern) and
the Swiss Association of Equine Practitioners. The new Equinella
is based on a user-friendly web-based platform (functional since
November 2013) and allows registered veterinarians to report
symptoms and equine diseases either using computers or
portable devices. Participants beneﬁt from various non-monetary
incentives: access to a table and interactive map of all incoming,
anonymized reports, a monthly newsletter and a mobile phone
text message service to alarm them in case of an outbreak.
Furthermore, they can contact and draw from the expertise of the
Equinella specialists team and attend one free professional
development course per year. Outdoor smartphones were pro-
vided to those interested. To facilitate and standardize data
collection veterinarians can choose clinical symptoms or diseases
from pre-deﬁned checklists. Data on the equid and the holding
are collected (no unique identiﬁers required to preserve ano-
nymity). Additional information can be entered in a free text box
and pictures can be uploaded. A reminder email is automatically
sent to all registered veterinarians (n¼ 77, 31.08.2015) once a
month. Recipients can then either conﬁrm that they had no
clinical observations of relevance to Equinella in their practice in
the previous month or report their observations retrospectively.
The monthly proportion of veterinarians that either submitted a
report or conﬁrmed not having observed any relevant cases var-
ied between 41.6% and 87.2% (median ¼ 71.4%). A total of 262
reports were submitted (November 2013 - August 2015; median
cases per month: 8 (min¼2, max¼48)): 82 (31.3%) included only
symptoms, 40 (15.3%) only diseases and 140 (53.4%) had both.
EHV-1 and Strangles were most frequently diagnosed (clinical
and/or laboratory diagnosis), whereas fever of unknown origin
was the most frequently reported symptom. Equinella currently
covers 50% of the Swiss equine population. Near real-time anal-
ysis of the Equinella data beneﬁt the early detection of new, exotic
and re-emerging equine diseases; thereby allowing appropriate
measures in a timely manner for the protection of the equine
population. Furthermore, experiences with Equinella might help
establishing similar early disease detection systems for other
animal species.
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